Catalog Advanced Search
171 Results
-
1 new product(s) added recently
In accordance with the Medication Access and Training Expansion (MATE) Act, beginning June 7, 2023, all providers who are registered with the DEA are required to complete 8 hours of training on the treatment and management of patients with opioid and other substance use disorders. This bundle fully satisfies this one-time requirement. | $210 Participants can earn 9 CE/CME hours, including 8.5 pharmacology hours. 9 CE/CME category 1 credits; 8.5 are pharmacology | $210
-
Register
- User - $210
- More Information
-
Register
-
Includes Credits
During this presentation learners will be engaged by this dynamic speaker on Abdominal trauma. Discussion will include the causes and how to evaluate and how to treat. Abdominal assessment and evaluation will be reviewed in detail. 1.0 CE/CME category 1 (0 Pharmacology) | $27.50
-
Register
- User - $27.50
- More Information
-
Register
-
Includes Credits
This fun and enlightening presentation for primary care providers will evaluate safe and effective prescribing by considering more than just medication costs. Cost-effective prescribing also means avoiding drug-drug and drug-disease interactions so that patients get the most out of the medications they take. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40
-
Register
- User - $40
- More Information
-
Register
-
Includes Credits
This talk will discuss the recognition, diagnosis and management of various abdominal emergencies. 1.0 CE/CME category 1 (0 Pharmacology) | $27.50
-
Register
- User - $27.50
- More Information
-
Register
-
This dynamic bundle focuses on equipping acute care APPs with the skills and confidence to effectively manage acute patient care. Through case studies, simulations, and guided discussions, participants will learn to quickly recognize early signs of patient deterioration, initiate appropriate interventions, and collaborate with interdisciplinary teams under high-pressure conditions. The sessions cover rapid assessment techniques, communication strategies during emergencies, and documentation best practices to ensure continuity of care. The advanced care provider will leave with enhanced critical thinking abilities and practical tools to improve patient outcomes in acute care situations. This bundle has 8 packed sessions that is a must for any acute care provider. | $160 Participants can earn 7.50 CE/CME hours, including 5 pharmacology hours. 7.50 CE/CME category 1 credits; 5 are pharmacology | $160
-
Register
- User - $160
- More Information
-
Register
-
Includes CreditsFeatured Deal
Merck Grant Funded Program The overall goal of this program is to address the barriers in vaccination uptake and integration. | 1.0 credits (1.0 pharmacology) | $10.00
-
Register
- User - $10
- More Information
-
Register
-
Includes Credits
This session discusses the diagnosis and treatment of hypogonadism and testosterone replacement. What we can and cannot give and what the latest data tells us. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30
-
Register
- User - $30
- More Information
-
Register
-
Includes Credits
In this session we will be highlighting the evaluation, treatment options and management of erectile dysfunction and hypogonadism – two of the most common men’s health issues. |1.0 CE/CME category 1 (0.75 Pharmacology) | $30
-
Register
- User - $30
- More Information
-
Register
-
Includes Credits
This interactive case-based discussion reviews the role of the Acute Care NP in recognizing and managing difficult airways of critically ill and injured patients. Airway assessment tools and positioning strategies are reviewed in detail. A variety of advanced airway tools are thoroughly examined, including pros and cons of each. Additionally, medications to aide in airway management are covered to equip the Acute Care NP knowledge to safely prescribe during the stressful situations of difficult airway management. 1.0 CE (0.50 Pharmacology) | $30
-
Register
- User - $30
- More Information
-
Register
-
Includes Credits
An update on the current landscape of Alzheimer's diagnosis and treatment, characterized by rapid advances in biomarker-driven diagnosis, the emergence of anti-amyloid and anti-tau therapies, and ongoing challenges in translating clinical trial results into real-world practice, including an update on the integration of novel imaging and plasma biomarkers, and the evolving therapeutic pipeline with monoclonal antibodies and other disease-modifying strategies. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $30
-
Register
- User - $30
- More Information
-
Register
